AMZN

205.22

-1.7%↓

TSLA

367.79

-3.26%↓

HD

321.07

-2.19%↓

TM

204.88

-1.93%↓

MCD

309.43

-0.1%↓

AMZN

205.22

-1.7%↓

TSLA

367.79

-3.26%↓

HD

321.07

-2.19%↓

TM

204.88

-1.93%↓

MCD

309.43

-0.1%↓

AMZN

205.22

-1.7%↓

TSLA

367.79

-3.26%↓

HD

321.07

-2.19%↓

TM

204.88

-1.93%↓

MCD

309.43

-0.1%↓

AMZN

205.22

-1.7%↓

TSLA

367.79

-3.26%↓

HD

321.07

-2.19%↓

TM

204.88

-1.93%↓

MCD

309.43

-0.1%↓

AMZN

205.22

-1.7%↓

TSLA

367.79

-3.26%↓

HD

321.07

-2.19%↓

TM

204.88

-1.93%↓

MCD

309.43

-0.1%↓

Search

Medifast Inc

Uždarymo kaina

SektoriusVartotojų cikliškumas

9.99 -0.7

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

9.93

Max

10.15

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-16M

-18M

Pardavimai

-14M

75M

P/E

Sektoriaus vid.

530

33.36

Pelno marža

-24.128

Darbuotojai

380

EBITDA

-5.1M

-4.3M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+20% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-27

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-7.9M

110M

Ankstesnė atidarymo kaina

10.69

Ankstesnė uždarymo kaina

9.99

Naujienos nuotaikos

By Acuity

43%

57%

112 / 338 reitingas Consumer cyclical

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Medifast Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-22 23:50; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-22 23:50; UTC

Rinkos pokalbiai

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

2026-03-22 23:49; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

2026-03-22 23:49; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

2026-03-22 23:49; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-22 23:41; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

2026-03-22 22:57; UTC

Įsigijimai, susijungimai, perėmimai

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

2026-03-22 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

2026-03-22 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

2026-03-22 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Perseus Mining: Participated in Aurum Resources Equity Raising

2026-03-22 22:54; UTC

Įsigijimai, susijungimai, perėmimai

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

2026-03-22 22:22; UTC

Rinkos pokalbiai
Svarbiausios naujienos

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

2026-03-22 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

2026-03-22 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

2026-03-22 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

2026-03-22 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

2026-03-22 21:53; UTC

Uždarbis

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

2026-03-22 21:53; UTC

Uždarbis

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

2026-03-22 21:53; UTC

Uždarbis

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

2026-03-22 21:53; UTC

Uždarbis

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

2026-03-22 21:31; UTC

Uždarbis

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

2026-03-22 21:31; UTC

Uždarbis

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

2026-03-22 21:31; UTC

Uždarbis

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

2026-03-22 21:31; UTC

Uždarbis

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

2026-03-22 21:31; UTC

Uždarbis

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

2026-03-22 21:25; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

2026-03-22 21:22; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

2026-03-22 21:21; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

2026-03-22 21:21; UTC

Rinkos pokalbiai

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

2026-03-22 21:21; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Akcijų palyginimas

Kainos pokytis

Medifast Inc Prognozė

Kainos tikslas

By TipRanks

20% į viršų

12 mėnesių prognozė

Vidutinis 12 USD  20%

Aukščiausias 12 USD

Žemiausias 12 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Medifast Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

12.35 / 12.98Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

112 / 338 reitingas Vartotojų cikliškumas

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Medifast Inc

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States and the Asia-Pacific. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
help-icon Live chat